BRUSSELS — Bruised by major disruptions in supplies of the AstraZeneca and Johnson & Johnson vaccines, the European Union Wednesday announced it was putting trust and money into the Pfizer-BioNTech shot to salvage its vaccination rollout and secure doses for the future.
The pivot away from AstraZeneca, once a pillar of the E.U. inoculation program, comes after months of discord over delayed shipments and as the company battles worries over rare potential side effects of its shots.
In announcing the change in strategy, Ursula von der Leyen, president of the European Commission, said Pfizer had agreed to an early shipment of doses thatshe said should likely allow the bloc to reach its goal of inoculating 70 percent of adults by the end of the summer.
That goal was in jeopardy after AstraZeneca failed to deliver on expected doses in the first quarter of the year, then suffered fresh setbacks over potential side effects related to blood clots. The European vaccine campaign was dealt a further blow Tuesday when Johnson & Johnson said it would delay its own rollout in Europe because of similar concerns and after regulators paused its use in the United States.
supply disruptions from AstraZeneca in late January, and then with the emergence of the potential rare blood disorder that has battered the public’s confidence in vaccines and led to appointment cancellations.
“As we can see with the announcement by Johnson & Johnson yesterday, there are still many factors that can disrupt the planned delivery schedules of vaccines,” Ms. von der Leyen said Wednesday.
Ms. von der Leyen said the Pfizer doses under negotiation for the next two years would include potential booster shots to extend the immunity of people who have already been inoculated, as well as possible new shots or boosters targeting emerging variants that might prove resilient against existing vaccines.
The AstraZeneca and Johnson & Johnson vaccines performed well in clinical trials and the possible dangerous side effects have been rare. But trials of the Pfizer and Moderna shots shows that they were even more effective in preventing infection, and similar side effects have not emerged. Another mRNA vaccine, from CureVac, is in clinical trials.
On Wednesday, the European Medicines Agency, the bloc’s top drug regulator, said it was expediting its investigation of “very rare cases of unusual blood clots” in recipients of the Johnson & Johnson vaccine, and expected to issue a recommendation next week. While the evaluation is ongoing, the agency reiterated its view that the benefits of the vaccine outweigh the risks.
In a setback for AstraZeneca, Denmark on Wednesday became the first country to permanently stop the administration of the company’s vaccine, saying the potential side effects were significant enough to do so given that it had the pandemic under control and could rely on the Pfizer and Moderna inoculations.
With the fresh commitment by Pfizer to bring forward the delivery of 50 million doses originally slated for the end of the year, the company expects to deliver 250 million doses in total to the bloc by the end of June.
Ms. von der Leyen said more than 100 million people in the European Union had already received at least one vaccine dose, and 27 million had received both. The additional Pfizer vaccines, together with 35 million doses expected from Moderna over the next three months, and a more limited use of AstraZeneca doses already in the pipeline, should likely be enough to get the bloc to the coveted milestone of reaching 255 million people by September, E.U. officials said.
In stark contrast to the criticism of AstraZeneca’s handling of its E.U. dealings, Ms. von der Leyen praised Pfizer effusively, highlighting how important the company’s ability to respond quickly to help the European Union has been.
“I want to thank BioNTech/Pfizer; it has proven to be a reliable partner,” Ms. von der Leyen said. “It has delivered on its commitments, and it is responsive to our needs.”
Addressing another sore point, Ms. von der Leyen said that the future Pfizer doses would be produced in the European Union.
Ample exports from the factories within the bloc to the rest of the world have enabled countries like Mexico and Canada to launch their vaccination campaigns, but those exports have also been identified as one reason there weren’t enough vaccines to go around in Europe.
The United States and Britain, by contrast, held tight to the vaccines made in their countries, helping speed along their inoculation efforts.
Denmark on Wednesday became the first country to plan to permanently stop administering the AstraZeneca vaccine, a month after suspending its use following reports that a small number of recipients had developed a rare but serious blood-clotting disorder.
The director general of the country’s health authority, Soeren Brostroem, said Denmark was able to halt use of the vaccine because it had the pandemic under control and could rely on two other vaccines, from Pfizer and Moderna.
The Danish announcement is another setback for the AstraZeneca shot, which is easy to store and relatively cheap, and was expected to be the foundation of vaccination campaigns around the world.
The country initially suspended the use of the vaccine on March 11, along with Iceland and Norway. Several other European countries, including France, Germany and Italy, followed suit last month.
later recommended that countries keep using the vaccine, saying its benefits far outweighed any potential risks for most people.
Last week, though, the European regulator listed blood clots as a potential very rare side effect of the vaccine.
Several countries that had paused and restarted use of the vaccine have since said they would stop using it in younger people. Britain, which has administered around 20 million AstraZeneca doses, said it would offer alternative vaccines to people under 30.
“Based on the scientific findings, our overall assessment is there is a real risk of severe side effects associated with using the Covid-19 vaccine from AstraZeneca,” Dr. Brostroem, the Danish health official, said in a statement. “We have, therefore, decided to remove the vaccine from our vaccination program.”
“If Denmark were in a completely different situation and in the midst of a violent third outbreak, for example, and a health care system under pressure,” he added, “then I would not hesitate to use the vaccine, even if there were rare but severe complications associated with using it.”
Danish health officials said that they might reintroduce the AstraZeneca vaccine “if the situation changes.”
Public health officials have warned that pausing administration of vaccines like AstraZeneca’s or Johnson & Johnson’s could do more harm than good. They note that among seven million people vaccinated with the single-dose Johnson & Johnson vaccine in the United States, six women had developed the rare blood clots — fewer than one in one million. It is not yet known whether the vaccine had anything to do with the clots, but even if it did, the risk is smaller than that of getting struck by lightning in a given year (one in 500,000).
Denmark, which has a population of 5.8 million, has managed to contain the pandemic better than its neighbor Sweden or many other European countries. As of Wednesday, Denmark had recorded 2,447 Covid-related deaths.
Almost one million people in the country have received at least a first dose of a vaccine, 77 percent of them the one from Pfizer, according to Denmark’s Serum Institute. Around 15 percent received a first dose of the AstraZeneca vaccine before the authorities suspended its use last month, and the remaining 8 percent received the Moderna vaccine.
The country’s health authorities said that people who received a first dose of the AstraZeneca vaccine would be offered a different vaccine for their second dose.
The European Union will receive an extra 50 million doses this month of the coronavirus vaccine developed by Pfizer and BioNTech, the leader of the bloc’s executive arm said on Wednesday, a lift in its effort to meet inoculation targets in the face of difficulties with vaccines developed by AstraZeneca and Johnson & Johnson.
The 27-nation bloc has also entered negotiations with Pfizer over the supply of 1.8 billion new vaccine doses — including booster shots to prolong immunity and new vaccines to tackle emerging variants — in 2022 and 2023, said Ursula von der Leyen, the president of the European Commission, its executive arm.
With these two announcements, the European Union embarked on a hard pivot to mRNA vaccines such as Pfizer’s, staking its coronavirus response on them, a day after Johnson & Johnson suspended the rollout of its vaccine in the European Union and as the bloc continued to suffer the fallout from restrictions on the AstraZeneca vaccine, after reports of extremely rare but serious potential side effects from both.
In another setback for AstraZeneca, Denmark on Wednesday became the first country to permanently stop the administration of the vaccine developed by the British-Swedish drugmaker. Denmark has heavily relied on Pfizer’s vaccine and has approved two others — Moderna’s, and Johnson & Johnson’s.
suffering blow after blow, first with major supply disruptions from AstraZeneca, and then as it has sought to respond to the reports of potential rare side effects.
Ms. von der Leyen’s announcements on Wednesday were significant in two ways.
Pfizer’s commitment to bring forward the delivery of the 50 million doses, which were originally slated for the end of the year, means the company will deliver a total of 250 million doses to the bloc by the end of June. Ms. von der Leyen said 100 million people in the European Union had already been inoculated.
But it also signaled that the bloc would seek to peg its strategy to tackle variants and the need for boosters in the medium term on mRNA vaccines, a newer technology being used by Pfizer and Moderna, moving away from vaccines based on other approaches like those from AstraZeneca and Johnson & Johnson.
“We need to focus now on technologies that have proven their worth: mRNA vaccines are a clear case in point,” Ms. von der Leyen said.
Ghalia al-Asseh had just begun studying chemistry and biotechnology at the Technical University of Denmark when the country’s immigration services summoned her for an interview.
For five hours, immigration officers asked about her proficiency in Danish, which she speaks fluently. They inquired how well integrated she was in Denmark, where she has lived with her family since fleeing Syria in 2015.
During the interview, in February, officers also told Ms. al-Asseh that the security situation in her hometown, Damascus, had improved, and that it was safe for her to return to Syria, she recalled in a telephone interview last week.
Ms. al-Asseh, 27, was losing her right to live in Denmark — even as her four brothers and parents could stay, and she had nowhere else to go.
not stable enough to be considered safe for returnees.
Those being asked to leave include high school and university students, truck drivers, factory employees, store owners and volunteers in nongovernmental organizations. All risk being uprooted from a country where they have built new lives.
“It is as if the Danish immigration services has bombed my dream, just as Bashar al-Assad bombed our homes,” said Asmaa al-Natour, 50, referring to Syria’s president. “Only this time the bombing is psychological.”
“ghettos,” and doubled punishments for certain crimes in these areas.
They have also overhauled the country’s legal apparatus on immigration, shifting it from integration to the accelerated return of refugees to their native countries. Hundreds of Somali refugees have also lost their residence permits after Denmark deemed Somalia safe to return to.
Per Mouritsen, an associate professor of political science at Aarhus University, said the government had toughened its stance on immigration in recent years to avoid losing votes to the right wing, a dilemma that several center-left parties across Europe have faced.
“The only way to beat the right-wing in Denmark is to sell your soul to the devil and be as tough on immigration in order to have support for social welfare policies in return,” Mr. Mouritsen said.
Last year, the number of refugees leaving Denmark exceeded the number of arrivals. Prime Minister Mette Frederiksen has vowed to go further, saying that Denmark will aim to have “zero asylum seekers.”
said in February.
For those willing to return to Syria, Mr. Tesfaye said that Denmark would offer “a huge bag of travel money.” The authorities say that hundreds decided to return voluntarily.
Michala Bendixen, Denmark’s country coordinator at Refugees Welcome, a nonprofit, said the policy threatened to tear Syrian families apart. “The only purpose is to make Denmark the last place to choose as an asylum seeker,” she said in an interview.
Because the Danish government does not maintain diplomatic relationships with Mr. al-Assad’s government, the authorities cannot forcibly deport refugees. Since most of them are unwilling to return voluntarily, those who lost their appeals after their residency was revoked are likely to be sent to departure centers.
The Danish authorities did not respond to questions about why the policy was implemented for Syrians and how many had been sent to departure centers.
collapsed economy and half of its prewar population displaced.Mr. al-Assad has reclaimed control of two-thirds of its territory, including the Damascus area. He has also called on Syrians to come back, but many say they won’t for one reason: Mr. al-Assad himself.
Syrian Network for Human Rights, and the European Union’s asylum body has warned that voluntary returnees are at risk of detention, torture and death.
“The absence of fighting in some areas does not mean that people can go back safely,” said Ms. Slente of the Danish Refugee Council.
Ms. al-Asseh, the chemistry and biotechnology student, said she had tried to focus on her studies since learning that her residency permit would be revoked. Yet she said the thought of starting over again terrified her.
“I’m not a danger. I’m not a criminal,” she said. “I just want to live here.”
In legal settlements that could reshape the children’s app market, Disney, Viacom and 10 advertising technology firms have agreed to remove certain advertising software from children’s apps to address accusations that they violated the privacy of millions of youngsters.
The agreements resolve three related class-action cases involving some of the largest ad-tech companies — including Twitter’s MoPub — and some of the most popular children’s apps — including “Subway Surfers,” an animated game from Denmark that users worldwide have installed more than 1.5 billion times, according to Sensor Tower, an app research firm.
The lawsuits accused the companies of placing tracking software in popular children’s gaming apps without parents’ knowledge or consent, in violation of state privacy and fair business practice laws. Such trackers can be used to profile children across apps and devices, target them with ads and push them to make in-app purchases, according to legal filings in the case.
Now, under the settlements approved on Monday by a judge in the U.S. District Court for the Northern District of California, the companies have agreed to remove or disable tracking software that could be used to target children with ads. Developers will still be able to show contextual ads based on an app’s content.
cases against individual developers and ad-tech firms. But children’s advocates said the class-action cases, which involved a much larger swath of the app and ad tech marketplace, could prompt industrywide changes for apps and ads aimed at young people.
Viacom, whose settlement covers one of its children’s apps, called “Llama Spit Spit,” Kiloo, a Danish company that codeveloped “Subway Surfers,” and Twitter declined to comment. Disney, whose settlement agreement covers its children’s apps in the United States, did not immediately response to emails seeking comment.
BRUSSELS — First it was AstraZeneca. Now Johnson & Johnson.
Last week, British regulators and the European Union’s medical agency said they had established a possible link between AstraZeneca’s Covid-19 vaccine and very rare, though sometimes fatal, blood clots.
On Tuesday, Johnson & Johnson said it would pause the rollout of its vaccine in Europe and the United States over similar concerns, further compounding the continent’s one-step-forward-two-steps-back efforts to quickly get people immunized against the coronavirus.
European officials had been confident that they had secured enough alternative vaccine doses to take up the slack of the AstraZeneca problems and achieve their goal of fully inoculating 70 percent of the European Union’s adult population — about 255 million people — by the end of the summer.
On Tuesday, European officials did not immediately say whether they believed the milestone would also survive the Johnson & Johnson suspension. But the European commissioner for health, Stella Kyriakides, wrote on Twitter that “Today’s developments with the J&J vaccine in the US are under close monitoring” by the bloc’s medicines regulator.
months of short supplies and logistical problems.
There is mounting evidence that the concerns are eroding Europeans’ willingness to get the AstraZeneca vaccine in particular, and threatening to elevate already high levels of vaccine hesitancy generally.
YouGov poll published last month, 61 percent of the French, 55 percent of Germans and 52 percent of Spaniards consider the AstraZeneca vaccine “unsafe.” That is in stark contrast to the findings of a similar poll from February, when more people in those countries, with the exception of France, believed that the shot was more safe than unsafe.
Regulators have asked vaccine recipients and doctors to be on the lookout for certain symptoms, including severe and persistent headaches and tiny blood spots under the skin. Doctors’ groups have circulated guidance about how to treat the disorder.
In Poland, where the vaccination campaign relies to a large extent on AstraZeneca and where its use has not been restricted, a recent poll showed that given a choice, fewer than 5 percent of Poles would choose the AstraZeneca shot.
Almost everywhere across the European Union, it seems, many are eager for alternatives, as the new types of vaccines that include the Moderna and Pfizer, which utilize science known as “mRNA,” have not been associated with similar side effects.
Data from the 27 E.U. member states by the European Center for Disease Prevention and Control shows that over all, 80 percent of vaccine doses distributed to the bloc have already been administered. That share drops to 65 percent for AstraZeneca, however, suggesting that many of its doses are sitting unused.
Yet it is hard to predict how serious a blow the latest twist in the AstraZeneca saga — and the new Johnson & Johnson concerns — will be to E.U. vaccination efforts, as officials in Brussels have made big if belated efforts to turbocharge the second-quarter supply of doses.
The European Union is poised to receive at least 300 million doses of various vaccines, three times what it got in the first quarter. Two hundred million are slated to come from Pfizer/BioNTech. Moderna is expected to deliver 35 million doses. Another 55 million doses are due of the Johnson & Johnson jab, and 70 million from AstraZeneca.
In the rosiest scenario, the European Union could get up to 360 million doses by June.
On Thursday, after Spain’s government changed the age threshold for the AstraZeneca shot, two-thirds of people called up for vaccination in Madrid did not show up, Antonio Zapatero, the regional health minister, told a news conference on Friday.
He attributed the no-show by 18,200 people to “confusion” generated by Spain’s central government, which said on Wednesday that the AstraZeneca vaccine should be given only to people over 60. Before this change, Mr. Zapatero said, the rate of abstention was 2 percent.
In Belgium, where the use of the AstraZeneca vaccine has also been limited, the authorities said they did not expect major delays in the overall rollout, but they are still concerned about the confusion that the rare blood clotting issue is causing.
Yves Van Laethem, a top epidemiologist who is the country’s Covid task force spokesman, said he expected a two-week delay that would mostly affect younger age groups in late summer. He said the E.U. regulator guidance had only partly helped in clarifying the situation.
The European Medicines Agency’s opinion “wasn’t very clear, and it is also part of the problem,” Dr. Van Laethem said in an interview. “When you say, ‘We don’t apply limitations, but we just say there are serious side effects,’ there is part science and part diplomacy in that.”
He said the limited effect that the new AstraZeneca issues would have on Belgian’s rollout was in large part because the country had ordered big shares of other vaccines.
Although all E.U. countries have been offered a chunk of each vaccine approved in the bloc so far — AstraZeneca, Johnson & Johnson, Moderna and Pfizer — many opted to forgo parts of their share of more expensive or cumbersome vaccines like Pfizer and Moderna early on, instead favoring the AstraZeneca jab.
“In Britain or Eastern Europe, a big part of the campaigns are based on AstraZeneca,” Dr. Van Laethem said.
Wealthier bloc members like Denmark, France, Germany and the Netherlands can better compensate for the loss of confidence in AstraZeneca, because they acquired extra doses of other vaccines — especially Pfizer — through a secondary market after poorer E.U. nations gave theirs up.
Those countries — including Bulgaria, Croatia, Latvia and Slovakia — are likely to be less able to quickly offer alternatives.
Dr. Van Laethem, the Belgian immunologist, said that the national and European authorities needed to better communicate the costs and benefits of taking the AstraZeneca dose versus and the other authorized vaccines.
Experts worry that even limited concerns over one vaccine’s unlikely side effects can affect people’s overall willingness to be immunized.
“The main thing is to make people understand that the problem is the virus,” he said. “We have to vaccinate people — the risk linked to the virus is higher than those rare side effects.”
Raphael Minder contributed reporting from Madrid and Constant Méheut from Paris.
Two reports published on Friday in a leading medical journal help to explain how AstraZeneca’s Covid vaccine can, in rare cases, cause serious and sometimes fatal blood clots.
Scientific teams from Germany and Norway found that people who developed the clots after vaccination had produced antibodies that activated their platelets, a blood component involved in clotting. The new reports add extensive details to what the researchers have already stated publicly about the blood disorder.
Why the rare reaction occurred is not known. Younger people appear more susceptible than older ones, but researchers say no pre-existing health conditions are known to predispose people to the problem, so there is no way to tell if an individual is at high risk.
Reports of the clots have already led a number of countries to limit AstraZeneca’s vaccine to older people, or to stop using it entirely. The cases have dealt a crushing blow to global efforts to halt the pandemic, because the AstraZeneca shot — easy to store and relatively cheap — has been a mainstay of vaccination programs in more than 100 countries.
statement on its website, AstraZeneca said it was “actively collaborating with the regulators to implement these changes to the product information and is already working to understand the individual cases, epidemiology and possible mechanisms that could explain these extremely rare events.”
The two new reports were published by The New England Journal of Medicine. One from Germany describes 11 patients, including nine women ages 22 to 49. Five to 16 days after vaccination, they were found to have one or more clots. Nine had cerebral venous thrombosis, a clot blocking a vein that drains blood from the brain. Some had clots in their lungs, abdomen or other areas. Six of the 11 died, one from a brain hemorrhage.
One patient had pre-existing conditions that affected clotting, but during a news briefing on Friday, Dr. Andreas Greinacher, an author of the report, said those conditions most likely played only a minor role in the disorder that occurred after vaccination.
second report, from Norway, described five patients, one male and four female health care workers ages 32 to 54, who had clots and bleeding from seven to 10 days after receiving the AstraZeneca vaccine. Four had severe clots in the brain, and three died. Severe headaches were among their early symptoms. Like the German patients, all had high levels of antibodies that could activate platelets.
The team from Norway also recommended treatment with intravenous immune globulin. The researchers said the disorder was rare, but “a new phenomenon with devastating effects for otherwise healthy young adults,” and they suggested that it may be more common than previous studies of the AstraZeneca vaccine had indicated.
On Friday, European regulators also said they were reviewing reports of a few blood clot cases that occurred in people who had received the Johnson and Johnson vaccine. In the United States, federal agencies are investigating reports of a different type of unusual blood disorder involving a precipitous drop in platelets that emerged in a few people who had received either the Pfizer-BioNTech or Moderna vaccines.
The death of Prince Philip, the husband of Queen Elizabeth II, at 99 on Friday came at the end of a year marked by mourning, with 150,000 lives lost to Covid-19 in Britain.
Buckingham Palace said that Prince Philip had died peacefully, and he was vaccinated against the coronavirus early this year, along with the queen.
Yet his death is likely to take on a new meaning in the middle of a pandemic, and to raise many questions: What will the funeral look like at a time of social distancing measures? With global travel restrictions in place, when will his grandson Prince Harry be able return from the United States with his wife, Meghan?
And with families across Britain unable to hold typical funerals for loved ones lost to Covid-19, how will the country’s most famous family mourn one of their own?
The palace said that a full outline would soon be released, and details began to emerge on Friday. The ceremony will not be a state funeral and will not be preceded by a lying-in-state, according to a statement from the College of Arms, which has created and maintained official registers of coats of arms and pedigrees since 1484.
“His Royal Highness’s body will lie at rest in Windsor Castle ahead of the funeral in St. George’s Chapel,” the statement said.
“The funeral arrangements have been revised in view of the prevailing circumstances arising from the Covid-19 pandemic,” it added, “and it is regretfully requested that members of the public do not attempt to attend or participate in any of the events that make up the funeral.”
Philip had been hospitalized in February for a heart problem and was discharged last month. Buckingham Palace said that his hospitalization was not related to the coronavirus.
But the privileges of royalty did not grant the family immunity from the virus.
Prince Charles — Prince Philip’s and Queen Elizabeth’s elder son and the heir to the throne — tested positive for the virus last year, as did Prince William, their grandson.
The queen has encouraged people in the country to be vaccinated. “Once you’ve had the vaccine, you have a feeling of, you know, you’re protected,” she said in a public call with health officials.
Britain is slowly emerging from a stringent national lockdown of recent months, with outdoor spaces in pubs and restaurants scheduled to reopen on Monday, as well as nonessential shops, gyms and hair salons. But many bereaved families of those lost to Covid-19 have said that as the country moves to brighter days, the staggering deaths of 150,000 people should not be forgotten.
Prime Minister Boris Johnson of Britain led tributes to Prince Philip on Friday, praising his lifelong support for Queen Elizabeth II and adding that he had “earned the affection of generations here in the United Kingdom, across the Commonwealth and around the world.”
“He was the longest-serving consort in history and one of the last surviving people in this country to have served in the Second World War,” Mr. Johnson said in a statement read in somber tones.
Referring to the prince’s hobby of driving horse-drawn carriages, Mr. Johnson added that “like the expert carriage driver that he was, he helped to steer the royal family and the monarchy so that it remains an institution indisputably vital to the balance and happiness of our national life.”
The leader of the opposition Labour Party, Keir Starmer, echoed those sentiments, saying that Britain had “lost an extraordinary public servant.”
“Prince Philip dedicated his life to our country — from a distinguished career in the Royal Navy during the Second World War to his decades of service as the Duke of Edinburgh,” Mr. Starmer added in a statement. “However, he will be remembered most of all for his extraordinary commitment and devotion to the queen.”
Scotland’s leader, Nicola Sturgeon, said that she was saddened by the news of Philip’s death and that she was sending her deepest condolences to the royal family.
Sadiq Khan, London’s mayor, said that he was grateful for the contributions Philip had made to the city, including his charity work, and that his legacy would positively impact the city for many years to come.
Lindsay Hoyle, the House of Commons speaker, also paid tribute, saying, “His was a long life that saw so much dedication to duty.”
In prerecorded remarks broadcast on ITV News, Theresa May, Mr. Johnson’s predecessor as prime minister, reflected on Philip’s supporting role: “It must be quite difficult for a male consort. They have to recognize their life is the monarch or head of state. But throughout his life, Prince Philip provided that strength, that rock, that reliable support and played an immensely important role,” she said.
With Queen Elizabeth in residence at Windsor Castle outside London, mourning the death of her husband, Prince Philip, on Friday, crowds gathered outside the gates of the world’s largest and oldest inhabited castle to pay their respects.
They came to leave flowers, take pictures and note the death of a member of an institution that — despite periods of deep turmoil — still commands respect and fascination.
Outside Buckingham Palace in central London, crowds also formed soon after the news of his death emerged.
A small girl unfurled a British flag on the pavement before the flowers laid at the gate of the magisterial royal home.
“I just have so much respect for Prince Philip and all he’s done,” said Britta Bia, 53. “I have so much respect for the royal family. I think they’ve done so much for charitable causes, and I think they’ve been upstanding citizens of the commonwealth.”
Lottie Smith, 18, said it was a moment to reflect on what really matters in life.
Ms. Smith and two friends who live in Greenwich heard of his death while they were on the train in to London, and decided to take a detour to the palace.
Catherine Vellacott, 19, said she hoped his death would “maybe unite the nation more.”
Peter Appleby, 22, flowers in hand, said that it was one more loss in a year marked by death.
“He’s had a hard year like everybody, and it doesn’t cost much to come and show a bit of respect,” he said.
Queen Elizabeth II, already Britain’s longest-serving monarch, passed a new milestone in 2017 when she and Prince Philip became the longest-married couple of the country’s royal family.
Where and when they first met remains unclear. He was invited to dine on the royal yacht when Elizabeth was 13 or 14. He was also invited to stay at Windsor Castle around that time while on leave from the Navy, and there were reports that he visited the royal family at Balmoral, its country estate in Scotland.
After that weekend, Elizabeth told her father, King George VI, that the naval officer was “the only man I could ever love.” Her father at first cautioned her to be patient.
Whisked off on a royal tour to South Africa, Elizabeth was said to have written to Philip three times a week. By the time she returned to England, Prince Philip of Greece and Denmark had renounced his foreign titles and become Lt. Philip Mountbatten, a British subject.
The engagement was announced on July 10, 1947.That year, on the eve of the wedding, Lieutenant Mountbatten was made the Duke of Edinburgh, Earl of Merioneth and Baron of Greenwich, and given the title His Royal Highness.
The prince, 26, married the young crown princess, who was 21, on Nov. 20, 1947, in a ceremony complete with horse-drawn coaches and a throng of adoring subjects lining the route between Buckingham Palace and Westminster Abbey.
The birth of their first child, Charles Philip Arthur George, on Nov. 14, 1948, at Buckingham Palace, was followed by Princess Anne, in 1950; Prince Andrew, in 1960, after Elizabeth became queen; and Prince Edward, in 1964.
In addition to the queen and their children, he is survived by eight grandchildren and eight great-grandchildren.
After his marriage, Prince Philip took command of the frigate Magpie in Malta. But King George VI had lung cancer, and when his condition worsened, it was announced that Philip would take no more naval appointments.
In 1952, the young couple were in Kenya, their first stop on a commonwealth tour, when word arrived on Feb. 6 that the king was dead. Philip broke the news to his wife.
The same year, the new queen ordained that Philip should be “first gentleman in the land,” giving him “a place of pre-eminence and precedence next to Her Majesty.”
Philip occupied a peculiar place on the world stage as the husband of a queen whose powers were largely ceremonial. He was essentially a second-fiddle figurehead, accompanying her on royal visits and sometimes standing in for her.
By royal warrant, the queen gave Philip the title Prince of the United Kingdom, bringing her husband’s name into the royal line.
While at times there were rumors of trouble in the marriage, their children’s marital difficulties overshadowed any discord between the parents.
Philip was born on the Greek island of Corfu on June 10, 1921, the fifth child and only son of Prince Andrew of Greece and Denmark, who was the brother of King Constantine of Greece. His mother was the former Princess Alice, the oldest daughter of the former Prince Louis of Battenberg, the first Marquess of Milford Haven, who changed the family name to Mountbatten during World War I.
Philip’s family was not Greek but rather descended from a royal Danish house that the European powers had put on the throne of Greece at the end of the 19th century. Philip, who never learned the Greek language, was sixth in line to the Greek throne.
Through his mother, Philip was a great-great-grandson of Queen Victoria, just as Elizabeth is Victoria’s great-great-granddaughter. Both were great-great-great-grandchildren of George III, who presided over Britain’s loss of the American colonies.
A year after Philip was born, the army of King Constantine was overwhelmed by the Turks in Asia Minor. Prince Andrew, Philip’s father, who had commanded an army corps in the routed Greek forces, was banished by a revolutionary Greek junta.
In “Prince Philip: The Turbulent Early Life of the Man Who Married Queen Elizabeth II” (2011), the British writer Philip Eade reported that as an infant Philip was smuggled out of Greece in a fruit crate as his father, eluding execution, found refuge for his family in Paris, where they lived in straitened circumstances.
Philip’s father was said to have been an Anglophile. The boy’s first language was English, taught to him by a British nanny. He grew to 6-foot-1, his blue eyes and blond hair reflecting his Nordic ancestry.
When his parents separated, Philip was sent to live with his mother’s mother, the Dowager Marchioness of Milford Haven, a granddaughter of Queen Victoria. He spent four years at the Cheam School in England, an institution bent on toughening privileged children, and then went to Gordonstoun School in Scotland, which was even more austere, promoting a regimen of hard work, cold showers and hard beds. In five years, he said, no one from his family came to visit him.
Even so, Philip sent his son Charles to both schools, to have him follow in his footsteps.
At Gordonstoun, Philip developed a love of the sea, learning seamanship and boatbuilding as a volunteer coast guardsman at the school. He seemed destined to follow his Mountbatten uncles into the British Navy.
Brusque, avuncular and with a reputation for being overly plain-speaking, Prince Philip over the years produced a collection of offensive, tone deaf and, on occasion, outrageous one-liners that were recorded by generations of British journalists.
His propensity to embarrass Buckingham Palace waxed and waned over the years, but never entirely faded even after decades of dinners, ceremonies and other engagements alongside Queen Elizabeth II. Some examples:
On a trip to Canada in 1969: “I declare this thing open, whatever it is.”
On another tour of Canada in 1976: “We don’t come here for our health. We can think of other ways of enjoying ourselves.”
During a recession in Britain in 1981: “Everybody was saying we must have more leisure. Now they are complaining they are unemployed.”
When accepting a figurine from a woman during a visit to Kenya in 1984: “You are a woman, aren’t you?”
Speaking to British students in China during a 1986 state visit: “If you stay here much longer, you’ll all be slitty-eyed.”
To a driving instructor in Oban, Scotland, in 1995: “How do you keep the natives off the booze long enough to pass the test?”
Suggesting to a British student in 1998 who had been trekking in Papua New Guinea that people there were still cannibals: “You managed not to get eaten, then?”
Visiting a factory in Edinburgh in 1999, pointing to an old-fashioned fuse box: “It looks as if it was put in by an Indian.”
Speaking to young deaf people in Cardiff, Wales, in 1999, referring to a school’s steel band: “Deaf? If you are near there, no wonder you are deaf.”
Meeting the president of Nigeria, who was dressed in traditional robes: “You look like you’re ready for bed!”
To a group of female Labour Party lawmakers at a party at Buckingham Palace in 2000: “Ah, so this is feminist corner then.”
As British leaders offered tributes and condolences, members of the royal family also offered personal recollections about Prince Philip.
His youngest son, Prince Edward, said in comments pre-recorded for ITV News that his parents had been “such a fantastic support to each other during all those years and all those events and all those tours and events overseas.”
“To have someone that you confide in and smile about things that you perhaps could not in public,” Edward said, “to be able to share that is immensely important.”
As for Philip’s occasionally abrasive interactions with the news media over the decades, Edward said that his father “used to give them as good as he got, and always in a very entertaining way.”
Edward, 57, added: “Anyone who had the privilege to hear him speak said it was his humor which always came through and the twinkle in his eye.”
Prince Philip’s daughter, Princess Anne, said that her father’s decision to give up his naval career demonstrated his level of commitment to Queen Elizabeth.
“It shows a real understanding of the pressure the queen was going through, and that the best way he could support her was on giving up on his career,” added Anne, 70.
“Without him,” she said, “life will be completely different.”
Leaders from around the world offered tributes to Prince Philip, the Duke of Edinburgh, who died on Friday, recalling his decades of service, his career in the Royal Navy and his role in Britain’s royal family.
Prime Minister Scott Morrison of Australia said in a statement that the prince had “embodied a generation that we will never see again.”
Prime Minister Narendra Modi of India said Philip “had a distinguished career in the military and was at the forefront of many community service initiatives.”
Prime Minister Justin Trudeau of Canada said the prince would be “remembered as a decorated naval officer, a dedicated philanthropist and a constant in the life of Queen Elizabeth II.”
“A man of great purpose and conviction, who was motivated by a sense of duty to others, Prince Philip contributed so much to the social fabric of our country — and the world,” Mr. Trudeau said.
Prime Minister Benjamin Netanyahu of Israel called Philip “the consummate public servant” and said he would be “much missed in Israel and across the world.”
Others to offer condolences included Prime Jacinda Ardern of New Zealand; Ursula von der Leyen, the president of the European Commission; Prime Minister Imran Khan of Pakistan; President Recep Tayyip Erdogan of Turkey; Nicola Sturgeon, Scotland’s leader; and Jean-Yves Le Drian, France’s foreign minister.
The White House had not responded as of Friday morning, but other former American officials, including former Vice President Mike Pence and President George W. Bush, offered their condolences.
“He represented the United Kingdom with dignity and brought boundless strength and support to the sovereign,” President Bush said in a statement. He added that he and his wife, Laura Bush, were “fortunate to have enjoyed the charm and wit of his company, and we know how much he will be missed.”
As concerns about climate change push the world economy toward a lower-carbon future, investing in oil may seem a risky bet. For the long term, that may be true.
Yet for the moment, at least, oil and gas prices appear likely to continue to rise as the economy recovers from the pandemic-driven shutdown of millions of businesses, big and small.
These countervailing trends — increasing demand now and falling demand at some point, perhaps in the not-too-distant future — create a dilemma for investors.
The good news is that an array of traditional mutual funds and exchange-traded funds are available to help them navigate these uncertain waters. Some funds focus on slices of the industry, such as extracting crude oil and gas from the ground or delivering refined products to consumers. Others focus on so-called integrated companies that do it all. Some spice their holdings with some exposure to wind, solar or other alternative energy sources.
International Energy Agency forecast that oil consumption was not likely to return to prepandemic levels in developed economies.
“World oil markets are rebalancing after the Covid-19 crisis spurred an unprecedented collapse in demand in 2020, but they may never return to ‘normal,’” the I.E.A. said in its “Oil 2021” report. “Rapid changes in behavior from the pandemic and a stronger drive by governments toward a low-carbon future have caused a dramatic downward shift in expectations for oil demand over the next six years.”
alternative energy funds. Many enable investors to zero in on discrete segments of the industry.
The biggest holdings of the Invesco WilderHill Clean Energy E.T.F. are producers of raw materials for solar cells and rechargeable batteries or builders and operators of large-scale solar projects. The $2.9 billion fund yields 0.49 percent and has an expense ratio of 0.7 percent.
The First Trust NASDAQ Clean Edge Green Energy Index Fund focuses on applied green technology. Its biggest holdings are Tesla, the American maker of electric automobiles; NIO, a Chinese rival in that field; and Plug Power, which makes hydrogen fuel cells for vehicles. Also a $2.9 billion fund, it yields 0.24 percent and has an expense ratio of 0.6 percent.
The First Trust Global Wind Energy E.T.F., as its name suggests, targets wind turbine manufacturers and servicers, led by the Spanish-German joint venture Siemens Gamesa Renewable Energy and Vestas Wind Systems of Denmark, as well as operators such as Northland Power of Canada. This $423 million fund yields 0.92 percent and has an expense ratio of 0.61 percent.
Greenland’s left-wing environmentalist party, Inuit Ataqatigiit, won a victory in national elections on Tuesday after campaigning against the development of a contentious rare earths mine partly backed by China.
The party, which had been in the opposition, won 37 percent of the vote over the longtime incumbents, the center-left Siumut party. The environmentalists will need to negotiate a coalition to form a government, but observers said their election win in Greenland, a semiautonomous territory of Denmark that sits on a rich vein of untapped uranium and rare earth minerals, signaled concerns from voters over the impact of mining.
“The people have spoken,” Múte B. Egede, the leader of Inuit Ataqatigiit, told the Danish broadcaster DR, adding that voters had made their position clear and that the mining project in Kvanefjeld in the country’s south would be halted.
Greenland Minerals, an Australian company behind the project, has said the mine has the “potential to become the most significant Western world producer of rare earths,” adding that it would create uranium as a byproduct. The company did not immediately respond to requests for comment on the vote.
rare earths, a crucial part of the high-tech global supply chain and used in the manufacture of everything from cellphones to rechargeable batteries, is currently dominated by China. Shenghe Resources, a Chinese rare earth company, owns 11 percent of Greenland Minerals.
Opposition to the Greenland mine, which the incumbent Siumut party had supported, played a primary role in its defeat, its leader, Erik Jensen, conceded in an interview with the Danish station TV2.
The mining project has been in development for years, with the government approving drilling for research, but not issuing final approval for the mine.
Among Greenlanders, opposition to the mine had grown over potential exposure of a unique, fragile area to “radioactive pollution and toxic waste,” said Dwayne Menezes, director of the Polar Research and Policy Initiative, a London-based think tank. “What they’re opposed to is dirty mining.”
The election result sent a clear message, Mr. Menezes added: Mining companies that want access to Greenland’s deposits will have to abide by stringent environmental standards and should look to give Greenlanders a “viable alternative.”
its polar seas become more navigable and as the melting ice unveils newly accessible resources, including the rare earths that play an essential part in the production of many alternative energy sources.
“On a global level, we are going to need to address head on this tension between Indigenous communities and the materials we are going to most need for a climate-stressed planet,” said Aimee Boulanger, executive director of the Initiative for Responsible Mining Assurance, a nonprofit.
Given China’s dominance over the global rare earth production and supply, Mr. Menezes said that Western countries should be looking for ways to enhance their partnerships with resource-rich Greenland to keep it in “their sphere of influence.”
Two years ago, Greenland’s lucrative resources and its increasing strategic importance led President Donald J. Trump to muse about purchasing the island. Greenland’s government, however, made clear that it was not for sale.
“We’re open for business, not for sale,” the island’s Ministry of Foreign Affairs posted on Twitter at the time.